High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? [electronic resource]
Producer: 20000713Description: 754-64 p. digitalISSN:- 0732-183X
- Activities of Daily Living
- Adenocarcinoma -- drug therapy
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Emotions
- Feasibility Studies
- Female
- Filgrastim
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Interpersonal Relations
- Middle Aged
- Neoadjuvant Therapy
- Patient Acceptance of Health Care
- Pilot Projects
- Quality of Life
- Recombinant Proteins
- Remission Induction
- Social Adjustment
- Statistics, Nonparametric
- Surveys and Questionnaires
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.